Gene · 49
Papers2,647
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
561 to 580 of 2,647
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| A systematic review and narrative synthesis of footwear and orthotic devices used in the management of ankle haemarthrosis and haemarthropathy in haemophilia. | Haemophilia | 2022 | 35245413 | PubTator, text mining | PubMed |
| The Effects of C. lacerata on Insulin Resistance in Type 2 Diabetes Patients. | J Diabetes Res | 2022 | 35242882 | PubTator, text mining | PubMed |
| Efficacy and safety of selective TYK2 inhibitor, deucravacitinib, in a phase II trial in psoriatic arthritis. | Ann Rheum Dis | 2022 | 35241426 | PubTator, text mining | PubMed |
| Safety and efficacy of autologous, adipose-derived mesenchymal stem cells in patients with rheumatoid arthritis: a phase I/IIa, open-label, non-randomized pilot trial. | Stem Cell Res Ther | 2022 | 35241141 | PubTator, text mining | PubMed |
| SPINKs in Tumors: Potential Therapeutic Targets. | Front Oncol | 2022 | 35223512 | PubTator, text mining | PubMed |
| Associations of Glycated Albumin and HbA1c with Chronic Kidney Disease in US Adults. | J Appl Lab Med | 2022 | 35213712 | PubTator, text mining | PubMed |
| Cognitive Impairment in Anti-Phospholipid Syndrome and Anti-Phospholipid Antibody Carriers. | Brain Sci | 2022 | 35203985 | PubTator, text mining | PubMed |
| Cannabinoids for the Treatment of Dermatologic Conditions. | JID Innov | 2022 | 35199092 | PubTator, text mining | PubMed |
| Validity and risk of adopting PGA ≤ 2 as a remission criteria of Boolean in clinical practice in patient with rheumatoid arthritis. | Sci Rep | 2022 | 35194126 | PubTator, text mining | PubMed |
| Aortic intima media thickness in children and adolescents with type 1 diabetes: A systematic review. | Pediatr Diabetes | 2022 | 35191150 | PubTator, text mining | PubMed |
| Retrospective Analysis of Factors Associated with Fracture in 714 Patients with Polymyalgia Rheumatica. | Int J Rheumatol | 2022 | 35190743 | PubTator, text mining | PubMed |
| Urinary Metabolomic Changes Accompanying Albuminuria Remission following Gastric Bypass Surgery for Type 2 Diabetic Kidney Disease. | Metabolites | 2022 | 35186675 | PubTator, text mining | PubMed |
| Imaging of neuroinflammation due to repetitive head injury in currently active kickboxers. | Eur J Nucl Med Mol Imaging | 2022 | 35165788 | PubTator, text mining | PubMed |
| The Impact of Intravenous Iron on Renal Injury and Function Markers in Patients With Chronic Kidney Disease and Iron Deficiency Without Anemia. | Kidney Int Rep | 2022 | 35155871 | PubTator, text mining | PubMed |
| Low cumulative disease activity is associated with higher bone mineral density in a majority Latinx and Asian US rheumatoid arthritis cohort. | Semin Arthritis Rheum | 2022 | 35152085 | PubTator, text mining | PubMed |
| Serum amyloid A-to-albumin ratio as a potential biomarker to predict the activity, severity, and poor prognosis of systemic lupus erythematosus. | J Clin Lab Anal | 2022 | 35141936 | PubTator, text mining | PubMed |
| Systematic review of the use of CRP in clinical trials for psoriatic arthritis: a concern for clinical practice? | RMD Open | 2022 | 35135860 | PubTator, text mining | PubMed |
| Adverse Effects of fine particulate matter on human kidney functioning: a systematic review. | Environ Health | 2022 | 35135544 | PubTator, text mining | PubMed |
| Plasminogen activator inhibitor-1 mediate downregulation of adiponectin in type 2 diabetes patients with metabolic syndrome. | Cytokine X | 2022 | 35128381 | PubTator, text mining | PubMed |
| Long-term safety and efficacy of upadacitinib or adalimumab in patients with rheumatoid arthritis: results through 3 years from the SELECT-COMPARE study. | RMD Open | 2022 | 35121639 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/49/papers?page=29